Join us at AACR 2025! Visit our poster session (Sun 4/27, 2-5PM CDT, Section 46, Poster 6) to see the latest developments from OncoKB™. See you there!

MTOR

Oncogene
Highest level of evidence:Level 3A
Also known as FRAP1, RAFT1, FRAP2, FRAP, FLJ44809, RAPT1
MTOR, an intracellular kinase that regulates cell growth and metabolism, is infrequently mutated in various cancer types.
Show MTOR background
NCBI Gene2475
Ensembl GeneENSG00000198793 (GRCh37/GRCh38)
Location
Chr1:11166592-11322564 (GRCh37)
Chr1:11106535-11262551 (GRCh38)
Ensembl TranscriptENST00000361445 (GRCh37/GRCh38)
RefSeqNM_004958.3 (GRCh37/GRCh38)
Annotated Mutations in MSK-IMPACT™ Clinical Sequencing Cohort (Zehir et al., Nat Med 2017)
A list of the cancer type-specific MTOR alterations that may predict response to a targeted drug and the corresponding OncoKB™ level of evidence assigning their level of clinical actionability.
If you notice any mistakes or omissions, please reach out to us.
Level
Alterations
Level-associated cancer types
Drugs
Citations
Description
Loading...